November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
December 15, 2025 - 01:14
The Legacy of the AV-8B Harrier: Pioneering Vertical Takeoff TechnologyThe AV-8B Harrier, often referred to as the `Jump Jet,` has played a crucial role in the evolution of vertical takeoff and landing (VTOL) aircraft. Although the Harrier is nearing the end of its...
December 14, 2025 - 03:01
ACC Baseball Programs Embrace Cutting-Edge Technology for Player DevelopmentIn a significant shift within NCAA Division I baseball, programs like Florida State University, the University of North Carolina, and the University of Virginia are making substantial investments...
December 13, 2025 - 00:29
Revolutionary Sensor Technology Enables Detection at the Smallest ScalesIn an exciting advancement for scientific research, new sensor technology has emerged that allows researchers to detect incredibly small entities, ranging from isolated proteins to individual...
December 12, 2025 - 10:46
Trump Issues Executive Order Preventing State-Level AI RegulationsCalifornia`s governor Gavin Newsom issued a strongly-worded statement in response to the executive order signed by Trump that blocks states from enforcing their own artificial intelligence...